Sana Biotechnology, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 30, 2027The maintenance fee for Methods and Compositions for Modulating Car-T Activity (US 11,802,157) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 2 fees due Aug 20, 2027
- 1 fee due Oct 23, 2027The maintenance fee for Methods and Compositions for Modulating Car-T Activity (US 11,965,022) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 22, 2026
- Oct 6 US 12,751,977 Methods and Compositions of Chondrisomes
- Aug 25 US 12,715,918 Methods and Compositions for Modulating Car-T Activity
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D991,484 | Cryogenic cassette In force · USPTO record | In force | USPTO record | |
| US D1,063,103 | Cryogenic Vial Storage Rack Assembly In force · High confidence | In force | High confidence | |
| US 12,751,977 | Methods and Compositions of Chondrisomes In force · Medium confidence | In force | Medium confidence | |
| US 11,903,974 | Methods and Compositions Relating to Chondrisomes from Cultured Cells In force · High confidence | In force | High confidence | |
| US 11,903,975 | Methods and Compositions Relating to Chondrisomes from Blood Products In force · High confidence | In force | High confidence | |
| US 11,802,157 | Methods and Compositions for Modulating Car-T Activity In force · High confidence | In force | High confidence | |
| US 11,965,022 | Methods and Compositions for Modulating Car-T Activity In force · High confidence | In force | High confidence | |
| US 11,987,628 | Methods and Compositions for Modulating Car-T Activity In force · High confidence | In force | High confidence | |
| US 11,535,869 | CD8-SPECIFIC Antibody Constructs and Compositions Thereof In force · High confidence | In force | High confidence | |
| US 12,674,180 | CD8-SPECIFIC Antibody Constructs and Compositions Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
33 pending · 7 abandoned · 6 no status recorded